|
|
|
Volumn 147, Issue 24, 2005, Pages 39-
|
|
Does the use of metoprolol-succinate in patients with chronic heart failure lead to a higher efficacy in treatment without causing additional costs?;Arzneimittelkosten werden durch einsparungen im krankenhaus kompensiert: Herzinsuffizienz-therapie mit betablocker ist kostenneutral
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
METOPROLOL SUCCINATE;
ARTICLE;
BETA ADRENERGIC RECEPTOR BLOCKING;
CHRONIC DISEASE;
COST EFFECTIVENESS ANALYSIS;
DRUG EFFICACY;
DRUG USE;
GERMANY;
HEALTH CARE COST;
HEART FAILURE;
HUMAN;
ADRENERGIC BETA-ANTAGONISTS;
COST SAVINGS;
DRUG COSTS;
GERMANY;
HEART FAILURE, CONGESTIVE;
HUMANS;
METOPROLOL;
NATIONAL HEALTH PROGRAMS;
PATIENT ADMISSION;
|
|
EID: 21444460114
PISSN: 14383276
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|
